A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
Clinical trial NCT02247739 · COMPLETED
Trial details
- NCT number
- NCT02247739
- Sponsor
- Pharming Technologies B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.